Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Grunebaum

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
Nouvelle Revue Francaise D'Hematologie|January 1, 1991
Anti-phospholipid auto-antibodies and thrombosisJ M Freyssinet, L Grunebaum, J Goetz, et al.
Gastroenterologie Clinique Et Biologique|January 1, 1990
[Biological manifestations of a prethrombotic state in developmental Crohn's disease]P Chamouard, L Grunebaum, B Duclos, et al.
La Revue De Medecine Interne|January 1, 1991
[Congenital deficiencies of natural anticoagulant systems responsible for recurrent thromboembolism]L Grunebaum, M L Wiesel, J M Freyssinet, et al.
Presse Medicale (Paris, France : 1983)|July 2, 1988
[Protein C: importance of its assay in pathology]M L Wiesel, L Grunebaum, J M Freyssinet, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 7, 2012
Late immune tolerance induction in an adult with severe haemophilia A and high-responder inhibitor: 1-year outcomeA Faradji, G Lavigne-Lissalde, L Grunebaum, et al.
Blood|October 1, 1986
A de novo intragenic deletion of the potential EGF domain of the factor IX gene in a family with severe hemophilia BM Vidaud, C Chabret, C Gazengel, et al.
Annales De Biologie Clinique|January 1, 1992
[Variations of plasma Willebrand factor and fibrinogen in coronary pathology]M L Wiesel, J M Mossard, L Grunebaum, et al.
Thrombosis Research|October 15, 1991
Potential thrombogenicity of angiographic contrast agentsM L Wiesel, M Zupan, F Wolff, et al.
Thrombosis and Haemostasis|November 24, 1989
Arterial thrombosis and protein S deficiencyP Sié, B Boneu, R Biermé, et al.
Journal Des Maladies Vasculaires|January 1, 1987
[Preliminary results of a randomized trial comparing the efficacy of standard heparin with that of fragmine, a low molecular weight heparin, in the prevention of postoperative thrombosis in cancer surgery]L Grunebaum, J P Fricker, M L Wiesel, et al.
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Nouvelle Revue Francaise D'Hematologie|January 1, 1991
Anti-phospholipid auto-antibodies and thrombosisJ M Freyssinet, L Grunebaum, J Goetz, et al.
Gastroenterologie Clinique Et Biologique|January 1, 1990
[Biological manifestations of a prethrombotic state in developmental Crohn's disease]P Chamouard, L Grunebaum, B Duclos, et al.
La Revue De Medecine Interne|January 1, 1991
[Congenital deficiencies of natural anticoagulant systems responsible for recurrent thromboembolism]L Grunebaum, M L Wiesel, J M Freyssinet, et al.
Presse Medicale (Paris, France : 1983)|July 2, 1988
[Protein C: importance of its assay in pathology]M L Wiesel, L Grunebaum, J M Freyssinet, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 7, 2012
Late immune tolerance induction in an adult with severe haemophilia A and high-responder inhibitor: 1-year outcomeA Faradji, G Lavigne-Lissalde, L Grunebaum, et al.
Blood|October 1, 1986
A de novo intragenic deletion of the potential EGF domain of the factor IX gene in a family with severe hemophilia BM Vidaud, C Chabret, C Gazengel, et al.
Annales De Biologie Clinique|January 1, 1992
[Variations of plasma Willebrand factor and fibrinogen in coronary pathology]M L Wiesel, J M Mossard, L Grunebaum, et al.
Thrombosis Research|October 15, 1991
Potential thrombogenicity of angiographic contrast agentsM L Wiesel, M Zupan, F Wolff, et al.
Thrombosis and Haemostasis|November 24, 1989
Arterial thrombosis and protein S deficiencyP Sié, B Boneu, R Biermé, et al.
Journal Des Maladies Vasculaires|January 1, 1987
[Preliminary results of a randomized trial comparing the efficacy of standard heparin with that of fragmine, a low molecular weight heparin, in the prevention of postoperative thrombosis in cancer surgery]L Grunebaum, J P Fricker, M L Wiesel, et al.
Pageof 5